Nicole E Chambers

Nicole E Chambers,

Postdoc Associate

Department: MD-PHARMACOLOGY / THERAPEUTICS
Business Email: nicole.chambers@ufl.edu

Research Profile

Mentor: Mark Moehle, PhD

Open Researcher and Contributor ID (ORCID)

0000-0003-2727-3327

Areas of Interest
  • Movement Disorders

Publications

2024
Deficits in basal and evoked striatal dopamine release following alpha‐synuclein preformed fibril injection: An in vivo microdialysis study
European Journal of Neuroscience. 59(7):1585-1603 [DOI] 10.1111/ejn.16275.
2023
The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders
Biochemical Society Transactions. 51(2):691-702 [DOI] 10.1042/bst20220525.
2021
Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
The European journal of neuroscience. 53(8):2835-2847 [DOI] 10.1111/ejn.15106.
2020
Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
Psychopharmacology. 237(1):155-165 [DOI] 10.1007/s00213-019-05353-6. [PMID] 31435690.
2019
Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat.
Neuroscience. 409:180-194 [DOI] 10.1016/j.neuroscience.2019.04.008. [PMID] 31029732.
2019
Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease.
Frontiers in pharmacology. 10 [DOI] 10.3389/fphar.2019.01494. [PMID] 32009944.
2019
Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia.
Acta neuropathologica communications. 7(1) [DOI] 10.1186/s40478-018-0653-7. [PMID] 30646956.
2018
A new outlook on cholinergic interneurons in Parkinson’s disease and L-DOPA-induced dyskinesia.
Neuroscience and biobehavioral reviews. 92:67-82 [DOI] 10.1016/j.neubiorev.2018.05.021. [PMID] 29782883.
2018
Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia.
Neuropharmacology. 138:304-314 [DOI] 10.1016/j.neuropharm.2018.06.024. [PMID] 29936243.
2018
Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats.
Movement disorders : official journal of the Movement Disorder Society. 33(11):1740-1749 [DOI] 10.1002/mds.100. [PMID] 30485908.
2017
Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia.
Experimental neurology. 292:168-178 [DOI] 10.1016/j.expneurol.2017.03.013. [PMID] 28342749.
2015
Relative reward effects on operant behavior: Incentive contrast, induction and variety effects.
Behavioural processes. 116:87-99 [DOI] 10.1016/j.beproc.2015.05.003. [PMID] 25979604.

Education

Ph.D. Behavioral Neuroscience
2014-2020 · Binghamton University
M.S. Psychological Science
2012-2015 · Western Kentucky University
B.A. Music, French, and Psychology (Triple Major)
2007-2012 · Bowling Green State University

Contact Details

Emails:
Addresses:
Business Mailing:
PO Box 100267
GAINESVILLE FL 32610